A hybrid transmission model for Plasmodium vivax accounting for superinfection, immunity and the hypnozoite reservoir S Mehra, PG Taylor, JM McCaw, JA Flegg Journal of Mathematical Biology 89 (1), 7, 2024 | 5 | 2024 |
Estimating the impact of test–trace–isolate–quarantine systems on SARS-CoV-2 transmission in Australia FM Shearer, JM McCaw, GE Ryan, T Hao, NJ Tierney, MJ Lydeamore, ... Epidemics 47, 100764, 2024 | 7 | 2024 |
Estimating measures to reduce the transmission of SARS-CoV-2 in Australia to guide a ‘National Plan’to reopening GE Ryan, FM Shearer, JM McCaw, J McVernon, N Golding Epidemics 47, 100763, 2024 | 6 | 2024 |
Investigation of P. Vivax Elimination via Mass Drug Administration MN Anwar, JM McCaw, AE Zarebski, RI Hickson, JA Flegg arXiv preprint arXiv:2405.20619, 2024 | | 2024 |
Investigation of P. Vivax Elimination via Mass Drug Administration M Nurul Anwar, JM McCaw, AE Zarebski, RI Hickson, JA Flegg arXiv e-prints, arXiv: 2405.20619, 2024 | | 2024 |
How immune dynamics shape multi-season epidemics: a continuous-discrete model in one dimensional antigenic space MG Roberts, RI Hickson, JM McCaw Journal of Mathematical Biology 88 (4), 48, 2024 | | 2024 |
Characterisation of Plasmodium vivax lactate dehydrogenase dynamics in P. vivax infections P Cao, S Kho, MJ Grigg, BE Barber, KA Piera, T William, ... Communications Biology 7 (1), 355, 2024 | | 2024 |
Mathematical models of Plasmodium vivax transmission: A scoping review MN Anwar, L Smith, A Devine, S Mehra, CR Walker, E Ivory, E Conway, ... PLOS Computational Biology 20 (3), e1011931, 2024 | 2 | 2024 |
Key challenges for respiratory virus surveillance while transitioning out of acute phase of COVID-19 pandemic O Eales, MJ Plank, BJ Cowling, BP Howden, AJ Kucharski, SG Sullivan, ... Emerging Infectious Diseases 30 (2), 2024 | 5 | 2024 |
Temporal trends in test-seeking behaviour during the COVID-19 pandemic O Eales, M Teo, DJ Price, T Hao, GE Ryan, KL Senior, S Carlson, ... medRxiv, 2024.06. 06.24308566, 2024 | | 2024 |
Biases in routine influenza surveillance indicators used to monitor infection incidence and recommendations for improvement O Eales, JM McCaw, FM Shearer medRxiv, 2024.06. 05.24308517, 2024 | | 2024 |
Optimal timing of booster doses in a highly vaccinated population with minimal natural exposure to COVID-19 E Conway, C Walker, M Lydeamore, N Golding, G Ryan, D Mavec, ... medRxiv, 2024.05. 14.24307386, 2024 | | 2024 |
Quantifying the impact of contact tracing interview prioritisation strategies on disease transmission LB Wu, CB Baker, N Tierney, K Carville, J McVernon, J McCaw, N Golding, ... medRxiv, 2024.04. 30.24306519, 2024 | | 2024 |
Border quarantine, vaccination and public health measures to mitigate the impact of COVID-19 importations: a modelling study MJ Lydeamore, C Zachreson, E Conway, FM Shearer, C Baker, J Ross, ... medRxiv, 2024.04. 22.24305704, 2024 | | 2024 |
Superinfection and the hypnozoite reservoir for Plasmodium vivax: a general framework S Mehra, JM McCaw, PG Taylor Journal of Mathematical Biology 88 (1), 7, 2024 | 3 | 2024 |
Seasonality as a driver of pH1N12009 influenza vaccination campaign impact KJ Bolton, JM McCaw, MP Dafilis, J McVernon, JM Heffernan Epidemics 45, 100730, 2023 | | 2023 |
Improving estimates of waning immunity rates in stochastic SIRS models with a hierarchical framework P Alahakoon, JM McCaw, PG Taylor Infectious Disease Modelling 8 (4), 1127-1137, 2023 | 5 | 2023 |
How effective were Australian Quarantine Stations in mitigating transmission aboard ships during the influenza pandemic of 1918-19? P Alahakoon, PG Taylor, JM McCaw PLOS Computational Biology 19 (11), e1011656, 2023 | | 2023 |
Spatial information allows inference of the prevalence of direct cell-to-cell viral infection T Williams, JM McCaw, J Osborne arXiv preprint arXiv:2310.19481, 2023 | | 2023 |
Individual variation in vaccine immune response can produce bimodal distributions of protection C Zachreson, R Tobin, J Szanyi, C Walker, D Cromer, FM Shearer, ... Vaccine 41 (45), 6630-6636, 2023 | 2 | 2023 |